Discovery’s Gentest® Hepatocytes were developed by Dr. Albert Li, a recognized leader in the refinement of liver cell cryopreservation.
Our portfolio includes Gentest® MetMax® permeabilized and co-factor supplemented human hepatocytes for metabolism studies as well as on-demand pre-plated hepatocytes with added convenience.
Our hepatocytes are prescreened for plateability, metabolic activity, cytochrome P450 (CYP) induction, and transporter efflux activity.
Discovery’s human liver microsomes (HLM) are a rich, convenient, and cost-effective source of native enzymes responsible for drug metabolism. They are ideal for metabolic stability, metabolite reactivity, drug-to-drug interactions, reaction phenotyping, and metabolite identification studies.
Gentest® UltraPool™ HLM 150 is the first commercially available large donor pool of HLMs from 150 donors that naturally represents the average patient population and known CYP polymorphisms.
Gentest® TransportoCells™ are HEK-293 cell-based products and include SLC transporter-expressing cells and ABC transporter inside-out vesicles.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: […]
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
